Nuvomedic Canna Consulting Ltd.

06/11/2026

I like these "new meds" 😂🤷‍♂️🤣

06/11/2026

Almost 90% of participants in a Canadian survey regard cannabis as an effective and safe pain management option for arthritis, with one in six having used it in the past month to treat severe joint pain.

Significantly, patients believed cannabis could treat over 50% of their pain and replace nearly half of their analgesic pain medications, with most feeling comfortable discussing cannabis use with their physicians.

Over 600 million people worldwide live with arthritis, and one in four of these report severe joint pain.

More in the comments.

06/11/2026

Can a Plant Help Fight the Fentanyl Crisis?

A newly published 2026 study found that inhaled cannabidiol (CBD), a non-intoxicating compound from cannabis, reduced fentanyl-seeking behavior in animal models while improving markers of cellular stress and aging within the central nervous system.

Researchers reported that CBD helped reverse signs associated with fentanyl addiction and restored biological balance in the brain.

The findings add to growing evidence that plant-derived compounds may have a role in addressing opioid dependence through mechanisms beyond traditional opioid replacement therapies.

With fentanyl responsible for hundreds of thousands of overdose deaths, innovative approaches are urgently needed.

While human studies are still required, this research highlights how botanical compounds continue to reveal unexpected therapeutic potential.

Science advances one study at a time. What was once dismissed as anecdotal is increasingly becoming a subject of serious biomedical investigation.

June 2026

Source Study: Khan A, Bhandari B. “Cannabidiol (CBD) and Fentanyl” (2026), published under an open-access license.

06/10/2026

Patients with fibromyalgia often report that cannabis helps manage their symptoms.

New clinical trial data provide even more evidence supporting their experiences: improvements in pain, sleep quality, anxiety, and depression.

"Clinically meaningful pain relief" for 70% of the treatment group in a clinical trial

06/08/2026

05/23/2026

A 44-year study has found that long-term cannabis use does not accelerate cognitive decline, challenging long-held assumptions about the drug’s impact on brain aging.

For decades, concerns about the long-term cognitive effects of cannabis have shaped public health warnings. But a large Danish study followed more than 5,000 men from early adulthood into their mid-sixties, comparing intelligence scores recorded at age 20 with follow-up assessments at age 64.

The findings, published in the journal Brain and Behavior, found no evidence that cannabis use speeds up cognitive decline. In fact, participants with a history of cannabis use showed a slightly smaller decrease in IQ — about 1.3 points less — compared to non-users, raising questions about the belief that cannabis inevitably harms long-term mental sharpness.

Researchers noted that factors such as lifestyle and “cognitive reserve” may help explain the results. Cannabis users in the study often had higher baseline IQs and education levels, both linked to greater cognitive resilience. Importantly, the study also found that neither frequency of use nor the age at which someone began using cannabis had a significant effect on intelligence later in life.